AstraZeneca is evaluating its oral IRAK4 inhibitor AZD6793 in a [...]
AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]
AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]
Tozorakimab has met its primary endpoint in two replicate Phase [...]
Bringing you the latest industry news and insights every day
Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596
© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design
